SavedAdd your journal

Journals / Türkiye Diyabet ve Obezite Dergisi / 2020 / Cilt: 4 - Sayı: 2

The Prognosis of “COVID-19 Pandemic and Obesity”: What We Learned from the Double Pandemic?

“COVID-19 Pandemisi ve Obezite” Prognozu: İki Pandemiden Ne Öğrendik?

Faruk KUTLUTÜRK
Taner BAYRAKTAROĞLU
Sakin TEKİN
Pages
138–146
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, the literature data in the COVID-19 pandemic regarding the role and the clinical value of obesity, adipose tissue and adipocytes in disease physiopathology, and the prognosis of pandemic and obesity are presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The course of mortality and morbidity of COVID-19 disease is seen higher than expected.
📊
Key Findings & Data:The presence of advanced age, male gender, obesity, hypertension, diabetes mellitus and chronic diseases were noteworthy in the COVID-19 pandemic, which occured in December 2019 worldwide.
💡
Conclusion & Impact:Here, the literature data in the COVID-19 pandemic regarding the role and the clinical value of obesity, adipose tissue and adipocytes in disease physiopathology, and the prognosis of pandemic and obesity are presented.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:COVID-19 · PANDEMİ · OBEZİTE

Abstract

The course of mortality and morbidity of COVID-19 disease is seen higher than expected. The presence of advanced age, male gender, obesity, hypertension, diabetes mellitus and chronic diseases were noteworthy in the COVID-19 pandemic, which occured in December 2019 worldwide. Obesity has been one of the considerable risk factors for mortality and morbidity for the patients with the clinical features of COVID-19 clinic. Here, the literature data in the COVID-19 pandemic regarding the role and the clinical value of obesity, adipose tissue and adipocytes in disease physiopathology, and the prognosis of pandemic and obesity are presented.

Özet

COVID-19 hastalığının mortalitesi ve morbiditesi beklenenden yüksek seyretmektedir. Dünya genelinde Aralık 2019’da başlayan COVID-19 pandemisinde hayatını kaybedenlerde ileri yaş, erkek cinsiyet, obezite, hipertansiyon, diabetes mellitus ve kronik hastalıkların varlığı dikkati çekmekteydi. Bilinen bir virüsün yaptığı pandemi, bilinmeyenlerle dolu bir hastalık tablosu olarak karşımıza çıkmıştır. Obezite, COVID-19’lu hastalarda mortalite ve morbidite açısından önemli risk faktörlerinden birisi olmuştur. Burada COVID-19 pandemisinde obezitenin yeri, klinik önemi, adipositler ve yağ dokusunun fizyopatolojiye katkısı, pandemi ve obezite prognozuna ait literatür verileri sunulmaktadır.

🔖

Cite This Article

KUTLUTÜRK, F., BAYRAKTAROĞLU, T., TEKİN, S. (2022). The Prognosis of “COVID-19 Pandemic and Obesity”: What We Learned from the Double Pandemic?. Türkiye Diyabet ve Obezite Dergisi, Cilt: 4 - Sayı: 2, 138–146. https://ajindex.com/articles/627928

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Becker, M.M. et al. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc. Natl. Acad. Sci. USA 105, 19944–19949 (2008). 2-Peiris, J.S., Guan, Y. & Yuen, K.Y. Severe acute respiratory syndrome. Nat. Med. 10, S88–S97 (2004). 3-Menachery VD, Yount BL Jr, Debbink K, et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence [published correction appears in Nat Med. 2016 Apr;22(4):446]. Nat Med. 2015;21(12):1508‐1513. doi:10.1038/nm.3985 4- World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. Available online at https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-COVID-19---11-march-2020, Accessed date: 20.05.2020. 5-World Health Organization. Coronavirus disease (COVID-19) pandemic. Available online at https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Accessed date: 11.06.2020. 6- Maier HE, Lopez R, Sanchez N, et al. Obesity increases the duration of influenza A virus shedding in adults. J Infect Dis. 2018;218(9):1378‐1382. [PMC free article] [PubMed] [Google Scholar]). 7-Neidich SD, Green WD, Rebeles J, et al. Increased risk of influenza among vaccinated adults who are obese. Int J Obes (Lond) 2017; 41:1324‐1330. 8-Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet 2015; 386: 995–1007. 9-Dietz W, Santos-Burgoa C. Obesity and its Implications for COVID-19 Mortality. Obesity (Silver Spring). 2020;28(6):1005. doi:10.1002/oby.22818. 10-Samuels JD. Obesity and severe COVID-19 disease: a strong association [published online ahead of print, 2020 May 4]. Obesity (Silver Spring). 2020;10.1002/oby.22866. doi:10.1002/oby.22866. 11-Kassir R. Risk of COVID-19 for patients with obesity. Obes Rev. 2020;21(6):e13034. doi:10.1111/obr.13034. 12-9-Finer N, Garnett SP, Bruun JM. COVID-19 and obesity. Clin Obes. 2020;10(3):e12365. doi:10.1111/cob.12365. 13-10-Hales K, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017‐2018. NCHS Data Brief, no. 360. Hyattsville, MD: National Center for Health Statistics; 2020.Google ScholarFull Text Article Linker 14-Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 states, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458-464. https://doi.org